Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 404

1.

Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells.

Lee SO, Pinder E, Chun JY, Lou W, Sun M, Gao AC.

Prostate. 2008 Jan 1;68(1):85-91.

PMID:
18008330
3.
4.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
5.

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.

Culig Z, Bartsch G, Hobisch A.

Mol Cell Endocrinol. 2002 Nov 29;197(1-2):231-8. Review.

PMID:
12431817
6.

Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.

Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B.

Prostate. 2008 Mar 1;68(4):453-61. doi: 10.1002/pros.20723.

PMID:
18196538
7.

Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer.

Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, Lokeshwar VB, Lokeshwar BL.

Cancer Res. 2007 Jul 15;67(14):6854-62.

8.

Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.

Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA.

Prostate. 2008 Jul 1;68(10):1133-42. doi: 10.1002/pros.20778.

PMID:
18454446
9.

Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .

Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC.

Prostate. 2000 Feb 15;42(3):239-42.

PMID:
10639195
10.

Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.

Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.

Cancer J. 2000 Jul-Aug;6(4):220-33.

PMID:
11038142
11.

Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice.

DeMiguel F, Lee SO, Lou W, Xiao X, Pflug BR, Nelson JB, Gao AC.

Prostate. 2002 Jul 1;52(2):123-9.

PMID:
12111703
12.

NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.

Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ.

Cancer Res. 2004 Aug 1;64(15):5489-95.

13.

Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10.

Ishikura N, Kawata H, Nishimoto A, Nakamura R, Ishii N, Aoki Y.

Prostate. 2010 Apr 1;70(5):457-66. doi: 10.1002/pros.21079.

PMID:
19902465
14.

Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.

Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R.

Cancer Res. 1995 Oct 1;55(19):4438-45.

15.

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.

Chen M, Feuerstein MA, Levina E, Baghel PS, Carkner RD, Tanner MJ, Shtutman M, Vacherot F, Terry S, de la Taille A, Buttyan R.

Mol Cancer. 2010 Apr 26;9:89. doi: 10.1186/1476-4598-9-89.

16.

Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.

Murthy S, Agoulnik IU, Weigel NL.

Prostate. 2005 Sep 1;64(4):362-72.

PMID:
15754350
17.

Interleukin-4 in patients with prostate cancer.

Takeshi U, Sadar MD, Suzuki H, Akakura K, Sakamoto S, Shimbo M, Suyama T, Imamoto T, Komiya A, Yukio N, Ichikawa T.

Anticancer Res. 2005 Nov-Dec;25(6C):4595-8.

18.

Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.

Siu SW, Lau KW, Tam PC, Shiu SY.

Prostate. 2002 Jul 1;52(2):106-22. Erratum in: Prostate 2002 Aug 1;52(3):252.

PMID:
12111702
19.

Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.

Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z.

Clin Cancer Res. 2001 Sep;7(9):2941-8.

20.

Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation.

Seaton A, Scullin P, Maxwell PJ, Wilson C, Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG, Waugh DJ.

Carcinogenesis. 2008 Jun;29(6):1148-56. doi: 10.1093/carcin/bgn109. Epub 2008 May 16.

Items per page

Supplemental Content

Write to the Help Desk